Clinical Trials Directory

Trials / Completed

CompletedNCT03096119

A Study to Define the Distribution of Type of Hypertension in Asia by Blood Pressure Monitoring at Home (Asia BP@Home)

Status
Completed
Phase
Study type
Observational
Enrollment
1,462 (actual)
Sponsor
Jichi Medical University · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

Blood pressure variability (BPV) is being increasingly recognized as an important influence on hypertension outcomes as well as a risk factor for other cardiovascular (CV) events. However, in Asia there is a current lack of awareness of BPV and its significance on patient outcomes. Furthermore, there is ongoing debate on the role of home blood pressure (HBP) monitoring in managing hypertension patients and uncertainty on how best to integrate it into clinical practice. Therefore, we conduct Asia BP@Home study to assess HBP control status in each Asian country and develop an Asian consensus and Asia-specific treatment for hypertension.

Detailed description

Blood pressure variability (BPV) is being increasingly recognized as an important influence on hypertension outcomes as well as a risk factor for other cardiovascular (CV) events. However, in Asia there is a current lack of awareness of BPV and its significance on patient outcomes. Furthermore, there is ongoing debate on the role of home blood pressure (HBP) monitoring in managing hypertension patients and uncertainty on how best to integrate it into clinical practice. The main purpose of this study is to: * Assess HBP control status in each Asian country * Develop an Asian consensus and Asia-specific treatment for hypertension * Improve the management of hypertension in Asia by encouraging patients to monitor HBP

Conditions

Interventions

TypeNameDescription
OTHERhome blood pressure measurementWe ask participants to measure their home blood pressure 7 days or more.

Timeline

Start date
2017-04-06
Primary completion
2018-03-31
Completion
2018-03-31
First posted
2017-03-30
Last updated
2018-04-17

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT03096119. Inclusion in this directory is not an endorsement.